$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018
Lloyd Price
JULY 5, 2018
Weeks after the company announced it would acquire Impact, Celgene plunked down another $9 billion to snap up Juno Therapeutics, a company in which it had already taken a $1 billion stake. The move provided Celgene with a therapy that could challenge rival drugmakers Novartis and Incyte in the myelofibrosis space. The deal will help open U.S.
40 
Let's personalize your content